Renaissance Technologies
IMMU

Renaissance Technologies’s Immunomedics Inc IMMU Stock Holding History

Renaissance Technologies’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-505,302
Closed -$10.7M – 3973
2019
Q4 		$10.7M Buy
+505,302
New +$8.91M 0.01% 1406
2018
Q4 		– Sell
-515,307
Closed -$10.7M – 3730
2018
Q3 		$10.7M Buy
515,307
+440,300
+587% +$10.4M 0.01% 1311
2018
Q2 		$1.77M Buy
+75,007
New +$1.51M ﹤0.01% 2330
2018
Q1 		– Sell
-230,474
Closed -$3.72M – 3674
2017
Q4 		$3.72M Sell
230,474
-1,206,133
-84% -$14.2M ﹤0.01% 1991
2017
Q3 		$20.1M Buy
+1,436,607
New +$14.3M 0.02% 900
2016
Q3 		– Sell
-1,772,807
Closed -$4.11M – 3559
2016
Q2 		$4.11M Buy
+1,772,807
New +$5.92M 0.01% 1728
2013
Q4 		– Sell
-260,207
Closed -$1.61M – 3085
2013
Q3 		$1.61M Buy
+260,207
New +$1.5M ﹤0.01% 1779

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies's IMMU Position: Q1 2020 in Review

Renaissance Technologies sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 505,302 shares — an estimated $10.7M sold.

Renaissance Technologies first reported a position in IMMU in Q3 2013 and held it in 7 quarters. The position peaked at $20.1M in Q3 2017. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Renaissance Technologies reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Renaissance Technologies sold 505,302 Immunomedics Inc shares in Q1 2020, an estimated $10.7M.
  • Renaissance Technologies first reported a position in Immunomedics Inc in Q3 2013 and held it in 7 quarters.
  • Renaissance Technologies's Immunomedics Inc position peaked at $20.1M in Q3 2017.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.